Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04402138
Title Treatment With Acalabrutinib Post Blood or Marrow Transplantation in Subjects With Mantle Cell Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors SCRI Development Innovations, LLC
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Colorado Blood Cancer Institute Denver Colorado 80218 United States Details
Tulane University, Office of Clinical Research New Orleans Louisiana 70112 United States Details
HCA Midwest Kansas City Missouri 64132 United States Details
Tennessee Oncology Nashville Tennessee 37302 United States Details
*Shaded cells indicate that there was no data available from for the field